All Stories

  1. Identification of naturally processed Zika virus peptides by mass spectrometry and validation of memory T cell recall responses in Zika convalescent subjects
  2. The role of systems biology approaches in determining molecular signatures for the development of more effective vaccines
  3. Current perspectives in assessing humoral immunity after measles vaccination
  4. Influenza vaccine failure: failure to protect or failure to understand?
  5. Rubella
  6. Celebrating the ACIP at 50
  7. Political, Ethical, Social, and Psychological Aspects of Vaccinology
  8. Perspective: Elimination round
  9. Vaccination as a Public Health Measure: Challenges
  10. High-Throughput Assay Optimization and Statistical Interpolation of Rubella-Specific Neutralizing Antibody Titers
  11. Are Impact Factors corrupting truth and utility in biomedical research?
  12. Edward Jenner and the discovery of vaccination—An appeal for the Edward Jenner Museum
  13. Visual Vaccinology – The Importance of Visual Communication
  14. Human Leukocyte Antigens and Cellular Immune Responses to Anthrax Vaccine Adsorbed
  15. Health Care Reform and Influenza Immunization
  16. Influenza vaccine and Guillain-Barré syndrome: making informed decisions
  17. United Nations mercury treaty jeopardizes vaccine protection of the world's most vulnerable children
  18. The Importance of Peer Review
  19. Smallpox and vaccinia
  20. Plagiarism, self-plagiarism, scientific misconduct, and VACCINE: Protecting the science and the public
  21. Nanovaccinology: The next generation of vaccines meets 21st century materials science and engineering
  22. HLA-DR specific monoclonal antibodies block lymphoproliferative response to measles vaccine in vitro: A pilot study
  23. Measles vaccination in health care personnel: Mandates, ethics, and patient safety
  24. Improving Adult Immunization
  25. Moving Adult Immunization Forward
  26. New influenza vaccines: Promises, perils, and pitfalls
  27. The Jenner Society and the Edward Jenner Museum: Tributes to a physician-scientist
  28. Methods in vaccine effectiveness and safety studies: A critical need for vaccine confidence
  29. Response to Dr. Norman W. Baylor's Letter to the Editor entitled: “Perspective of the U.S. Food and Drug Administration on Concomitant Administration of Zostavax and Pneumovax”
  30. Editor-in-Chief response
  31. MMR Vaccine and Autism: Vaccine Nihilism and Postmodern Science
  32. Vaccine education spectrum disorder: the importance of incorporating psychological and cognitive models into vaccine education
  33. Methodologic reporting requirements for clinical trials: Advancing the science today and tomorrow
  34. Vaccinomics: Current Findings, Challenges and Novel Approaches for Vaccine Development
  35. Sophiology, vaccinology, and the healing professions – A warning from ancient Greece?
  36. New author guidelines for VACCINE
  37. The day that Jack died☆
  38. From Science II to Vaccinology II: A new epistemology
  39. Pandemic 2009–2010 influenza vaccine: Six lessons learned and the way forward (Allegro not Adagio)
  40. Developing the next generation of vaccinologists
  41. Vaccinomics, predictive vaccinology and the future of vaccine development
  42. Vaccidents and adversomics
  43. Publishing in VACCINE: Ten lessons to improve your acceptance rate
  44. Prevention of Meningococcal Disease: Current Use of Polysaccharide and Conjugate Vaccines
  45. VACCINE in the 21st century: What's next?
  46. Dr. Greg Poland, Director of Mayo Vaccine Research Group, provides H1N1 updates (Part 1)
  47. Dr. Greg Poland, Director of Mayo Vaccine Research Group, discusses H1N1 updates (Part 2)
  48. Smallpox vaccines for biodefense
  49. Introduction to this supplement
  50. Application of pharmacogenomics to vaccines
  51. Smallpox
  52. Vaccines against Influenza A (H5N1): Evidence of Progress
  53. The Reply
  54. Breaking the immunogenicity barrier of bird flu vaccines
  55. Meta-analyses in vaccinology
  56. Avian and pandemic influenza: An overview
  57. Disaster Medicine
  58. Disaster Medicine
  59. T-Cell epitope discovery for variola and vaccinia viruses
  60. Is it time for universal influenza immunization?
  61. Is it time for universal influenza immunization?
  62. Is it time for universal influenza immunization?
  63. Importance of HLA-DQ and HLA-DP polymorphisms in cytokine responses to naturally processed HLA-DR-derived measles virus peptides
  64. Avian influenza vaccines: what's all the flap?
  65. Smallpox vaccines: from first to second to third generation
  66. Vaccines in the 21st century
  67. Conflict and Catastrophe Medicine: A Practical Guide
  68. Reply
  69. If You Could Halve the Mortality Rate, Would You Do It?
  70. Prevention of Lyme Disease: A Review of the Evidence
  71. Intranasal Influenza Vaccine
  72. Adult Immunizations: Recommendations for Practice
  73. Current paradoxes and changing paradigms in vaccinology
  74. The burden of pneumococcal disease: the role of conjugate vaccines
  75. Issues about pertussis vaccines
  76. Still more questions on pertussis vaccines
  77. Determination of Deltoid Fat Pad Thickness
  78. Vaccines
  79. Guide for Adult Immunization
  80. Concise Textbook of Medicine
  81. Influenza Vaccine
  82. MMR Vaccine and Autism: Vaccine Nihilism and Postmodern Science
  83. Detection of Measles Virus-Specific Interferon-γ-Secreting T-Cells by ELISPOT